Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Dual-action compounds for BPH described by Zeria

Feb. 10, 1997

Gruenenthal prepares analgesics

Feb. 10, 1997

Legionella vaccine described by U.S. researchers

Feb. 7, 1997

Nonantiresorptive substituted bisphosphonate disclosed by Gador

Feb. 7, 1997

Antiallergic/antiinflammatory agents from Senju

Feb. 7, 1997

Japanese researchers describe triazole antifungals

Feb. 7, 1997

Il Yang develops antitumor/immunostimulating proteoglycan

Feb. 7, 1997

Rockefeller University discloses antibiotic peptides

Feb. 7, 1997

Merck describes improved chemotherapeutic agents

Feb. 7, 1997

Peptide derivatives with antiinflammatory properties described by U.S. researchers

Feb. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.